Po‐Lin Tseng

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy

K.-C. Chang, Chien‐Hui Hung, S.-N. Lu et al. · Journal of Antimicrobial Chemotherapy · 2012 · 101 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect

Po‐Lin Tseng, Wei-Hsuan Wu, Tsung‐Hui Hu et al. · Scientific Reports · 2018 · 100 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Jing‐Houng Wang, Kuo‐Chin Chang, Kwong‐Ming Kee et al. · The American Journal of Gastroenterology · 2013 · 75 citations

Medicine, Community Health, Oncology +14

Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients

Po‐Lin Tseng, Ming‐Hong Tai, Chao‐Cheng Huang et al. · Journal of Surgical Oncology · 2008 · 71 citations

Medicine, Oncology, Pathology +16

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience

Ming‐Chao Tsai, Chia‐Hsiang Chen, Po‐Lin Tseng et al. · Clinical Microbiology and Infection · 2015 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +16